Wolverine Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Wolverine Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Hold	0	–	–	–	1741
2019 Q4	–	Hold	0	–	–	–	1555
2019 Q3	–	Hold	0	–	–	–	1664
2019 Q2	–	Hold	0	–	–	–	1628
2019 Q1	–	Hold	0	–	–	–	1761
2018 Q4	–	Hold	0	–	–	–	1793
2018 Q3	–	Hold	0	–	–	–	1668
2018 Q2	–	Hold	0	–	–	–	1632
2018 Q1	–	Hold	0	–	–	–	1723
2017 Q4	–	Sell	-1	Closed	-$83	–	1640
2017 Q3	$0	Buy	+1	New	+$77	﹤0.01%	1531
2014 Q4	–	Sell	-78	Closed	-$14K	–	2548
2014 Q3	$14K	Buy	+78	New	+$17.1K	﹤0.01%	1904

Other funds holding LUMO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wolverine Asset Management's LUMO Position: Q1 2020 in Review

Wolverine Asset Management held its Lumos Pharma, Inc. Common Stock (LUMO) position steady in Q1 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

Wolverine Asset Management first reported a position in LUMO in Q3 2014 and has held it in 2 quarters since. The position peaked at $14K in Q3 2014. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

Wolverine Asset Management held 0 shares of Lumos Pharma, Inc. Common Stock worth $0 as of Q1 2020.
Wolverine Asset Management left its Lumos Pharma, Inc. Common Stock share count unchanged in Q1 2020.
Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2020, its #1741 holding.
Wolverine Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2014 and has held it in 2 quarters since.
Wolverine Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $14K in Q3 2014.
46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Wolverine Asset Management's 13F filing for Q1 2020, filed 13 May 2020.